Cargando…
Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports
BACKGROUND: Vaccination remains the cornerstone approach to exiting the current global coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus 2. The novel messenger ribonucleic acid vaccines offer a high level of protection and are widely used throughout the world....
Autores principales: | Vutipongsatorn, Kritchai, Isaacs, Anthony, Farah, Ziad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801240/ https://www.ncbi.nlm.nih.gov/pubmed/35094715 http://dx.doi.org/10.1186/s13256-022-03266-1 |
Ejemplares similares
-
Patient Stratification in Sepsis: Using Metabolomics to Detect Clinical Phenotypes, Sub-Phenotypes and Therapeutic Response
por: Hussain, Humma, et al.
Publicado: (2022) -
Leveraging access to technology and enhanced surgical technique (LATEST) in laparoscopic bile duct exploration (LBDE)
por: Navaratne, Lalin, et al.
Publicado: (2022) -
Differences and diversity of autoimmune encephalitis in 77 cases from a single tertiary care center
por: Saraya, Abhinbhen W., et al.
Publicado: (2019) -
Inflammatory myopathy following coronavirus disease 2019 vaccination: A systematic review
por: Ding, Yukang, et al.
Publicado: (2022) -
Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice
por: Reeves, Patrick M., et al.
Publicado: (2017)